女性乳头状肾细胞癌手术患者行保留器官手术的比例更低:一项多中心研究
该回顾性多中心研究分析了1984至2015年间17个中心2325例接受手术的单侧乳头状肾细胞癌患者,评估性别对临床病理特征及生存的影响。结果显示女性接受保留肾单位手术(NSS)的比例显著低于男性,校正相关因素后男性行NSS的可能性高72%(P<.001);性别对肿瘤特异性死亡率(CSM)无显著影响,但在器官局限亚组中女性CSM低59%(P=.001)。
要点
- 女性乳头状肾细胞癌患者行保留肾单位手术的比例显著低于男性(P<.001)。
- 多因素分析校正后,男性行保留肾单位手术的可能性比女性高72%(P<.001)。
- 器官局限亚组中女性肿瘤特异性死亡率比男性低59%(P=.001),但整体队列无显著性别差异。
核心结论
- 在该大型乳头状肾细胞癌手术队列中,性别对生存无显著影响,但器官局限性疾病女性患者的肿瘤特异性死亡率似乎更低。
- 男性患者行保留肾单位手术的可能性似乎显著更高。
研究设计与样本
- 回顾性多中心队列研究,纳入1984至2015年间17个欧洲和北美中心2325例接受手术的单侧乳头状肾细胞癌患者,中位随访47个月。
主要发现
- 研究队列包括1782例(77%)男性患者,男女比例为3.3:1.0。
- 在年龄、就诊症状、体能状态、病理肿瘤大小、分期和分级方面,未观察到显著的性别差异。
- 女性患者接受保留肾单位手术的频率显著更低(P<.001);多因素分析校正所有相关协变量后,男性行保留肾单位手术的可能性高72%(P<.001)。
- 在肿瘤特异性死亡率和其他原因死亡率方面未显示显著的性别差异,但在器官局限肿瘤亚组(n=2075)中,女性肿瘤特异性死亡率低59%(P=.001);非器官局限肿瘤亚组(n=250)的分析未在摘要中报告具体结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the impact of gender on the clinicopathologic features and survival of patients with surgically treated papillary renal cell carcinoma (papRCC) using a comprehensive international multicenter database. MATERIALS AND METHODS: Data of 2325 patients undergoing surgery for unilateral papRCC between 1984 and 2015 in 17 European and North American centers were retrospectively collated. The impact of clinicopathologic features on the likelihood of nephron-sparing surgery (NSS) was evaluated using a multivariable logistic regression model. The influence on cancer-specific mortality (CSM) and other-cause mortality was analyzed by multivariable competing-risk regression models. Finally, subgroup analyses were conducted for organ-confined (n = 2075) and non-organ-confined tumors (n = 250). The median follow-up was 47 months. RESULTS: The study cohort included 1782 (77%) male patients (male-to-female ratio 3.3:1.0). Considering age, symptoms at presentation, performance status, pathologic tumor size, stage, and grade, we observed that there were no significant gender-specific differences. In contrast, female patients underwent NSS significantly less frequently (P <.001). On multivariable analysis, the likelihood of NSS was 72% higher in male patients after adjusting for all relevant cofactors (P <.001). No significant gender-specific differences in terms of CSM and other-cause mortality were demonstrated, but CSM was 59% lower in female patients in the subgroup of organ-confined tumors (P = .001). CONCLUSION: No impact of gender on survival was found analyzing this large cohort of patients undergoing surgery for papRCC. However, CSM appears to be lower in female patients with organ-confined disease. In this context, it is interesting that the likelihood of NSS seems to be significantly higher in male patients.
引用
- Wolff I, Scavuzzo A, Capitanio U, et al. Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study. Urology. 2017. PMID: 28802570. doi:10.1016/j.urology.2017.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。